{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:44:21Z","timestamp":1789908261116,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5658-5","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T16:54:02Z","timestamp":1557248042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0006-8104","authenticated-orcid":false,"given":"Leen","family":"Van de Sande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Willaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cosyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaat","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molood","family":"Shariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Ceelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"5658_CR1","doi-asserted-by":"publisher","unstructured":"Al Rawahi T, Lopes AD, Bristow RE, Bryant A, Elattar A, Chattopadhyay S, Galaal K. Surgical cytoreduction for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev. 2013;(2):CD008765. \n                    https:\/\/doi.org\/10.1002\/14651858.CD008765.pub3\n                    \n                  .","DOI":"10.1002\/14651858.CD008765.pub3"},{"key":"5658_CR2","first-page":"695","volume":"29","author":"A Oseledchyk","year":"2015","unstructured":"Oseledchyk A, Zivanovic O. Intraoperative Hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian Cancer. Oncology (Williston Park, NY). 2015;29:695\u2013701.","journal-title":"Oncology (Williston Park, NY)"},{"key":"5658_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","volume":"38","author":"YLB Klaver","year":"2012","unstructured":"Klaver YLB, Simkens LHJ, Lemmens VEPP, Koopman M, Teerenstra S, Bleichrodt RP, de Hingh IHJT, Punt CJA. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012;38:617\u201323. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2012.03.008\n                    \n                  .","journal-title":"Eur J Surg Oncol"},{"key":"5658_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE, de Hingh IH. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138. \n                    https:\/\/doi.org\/10.1002\/ijc.28373\n                    \n                  .","journal-title":"Int J Cancer"},{"key":"5658_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","volume":"42","author":"I Thomassen","year":"2013","unstructured":"Thomassen I, Lemmens VEPP, Nienhuijs SW, Luyer MD, Klaver YL, de Hingh IHJT. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study. Pancreas. 2013;42:72\u20135. \n                    https:\/\/doi.org\/10.1097\/MPA.0b013e31825abf8c\n                    \n                  .","journal-title":"Pancreas"},{"key":"5658_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-15-1620","volume":"76","author":"KK Winner","year":"2016","unstructured":"Winner KK, Steinkamp MP, Lee RJ, Swat M, Muller CY, Moses ME, Jiang Y, Wilson BS. Spatial modeling of drug delivery routes for treatment of disseminated ovarian cancer. Cancer Res. 2016;76:1320\u201334. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1620\n                    \n                  .","journal-title":"Cancer Res"},{"key":"5658_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.mehy.2015.07.001","volume":"85","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB. Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis. Med Hypotheses. 2015;85:480\u20134. \n                    https:\/\/doi.org\/10.1016\/j.mehy.2015.07.001\n                    \n                  .","journal-title":"Med Hypotheses"},{"key":"5658_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/bjs.10521","volume":"104","author":"F Grass","year":"2017","unstructured":"Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, H\u00fcbner M. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg. 2017;104:669\u201378. \n                    https:\/\/doi.org\/10.1002\/bjs.10521\n                    \n                  .","journal-title":"Br J Surg"},{"key":"5658_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","volume":"244","author":"P Esquis","year":"2006","unstructured":"Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, Beltramo J-L, Drogoul C, Simonet M, Benoit L, Rat P, Chauffert B. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244:106\u201312. \n                    https:\/\/doi.org\/10.1097\/01.sla.0000218089.61635.5f\n                    \n                  .","journal-title":"Ann Surg"},{"key":"5658_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1515\/pp-2016-0005","volume":"1","author":"M Reymond","year":"2016","unstructured":"Reymond M, Demtroeder C, Solass W, Winnekendonk G, Tempfer C. Electrostatic precipitation pressurized IntraPeritoneal aerosol chemotherapy (ePIPAC): first in-human application. Pleura and Peritoneum. 2016;1:109\u201316. \n                    https:\/\/doi.org\/10.1515\/pp-2016-0005\n                    \n                  .","journal-title":"Pleura and Peritoneum"},{"key":"5658_CR11","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00464-014-3427-8","volume":"28","author":"J Ansell","year":"2014","unstructured":"Ansell J, Warren N, Wall P, Cocks K, Goddard S, Whiston R, Stechman M, Scott-Coombes D, Torkington J. Electrostatic precipitation is a novel way of maintaining visual field clarity during laparoscopic surgery: a prospective double-blind randomized controlled pilot study. Surg Endosc. 2014;28:2057\u201365. \n                    https:\/\/doi.org\/10.1007\/s00464-014-3427-8\n                    \n                  .","journal-title":"Surg Endosc"},{"key":"5658_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1245\/s10434-016-5108-4","volume":"23","author":"T Kakchekeeva","year":"2016","unstructured":"Kakchekeeva T, Demtr\u00f6der C, Herath NI, Griffiths D, Torkington J, Sola\u00df W, Dutreix M, Reymond MA. In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol. 2016;23:592\u20138. \n                    https:\/\/doi.org\/10.1245\/s10434-016-5108-4\n                    \n                  .","journal-title":"Ann Surg Oncol"},{"key":"5658_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-017-1109-4","volume":"15","author":"V Khosrawipour","year":"2017","unstructured":"Khosrawipour V, Diaz-Carballo D, Ali-Haydar A, Khosrawipour T, Falkenstein TA, Wu D, Zieren J, Giger-Pabst U. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells. World J Surg Oncol. 2017;15:43. \n                    https:\/\/doi.org\/10.1186\/s12957-017-1109-4\n                    \n                  .","journal-title":"World J Surg Oncol"},{"key":"5658_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Herbette A, Schwarz T, Hetzel A, Sun J-S, Dutreix M, Reymond MA. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc. 2012;26:847\u201352. \n                    https:\/\/doi.org\/10.1007\/s00464-011-1964-y\n                    \n                  .","journal-title":"Surg Endosc"},{"key":"5658_CR15","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.21873\/anticanres.11008","volume":"36","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D, Foerster E, Osma A, Adamietz IA, Zieren J, Fakhrian K. Evaluating the effect of micropump (c) position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. Anticancer Res. 2016;36:4595\u2013600. \n                    https:\/\/doi.org\/10.21873\/anticanres.11008\n                    \n                  .","journal-title":"Anticancer Res"},{"key":"5658_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/pp-2017-0006","volume":"2","author":"D Schnelle","year":"2017","unstructured":"Schnelle D, Weinreich F-J, Kibat J, Reymond MA. A new ex vivo model for optimizing distribution of therapeutic aerosols: the (inverted) bovine urinary bladder. Pleura and Peritoneum. 2017;2:37\u201341. \n                    https:\/\/doi.org\/10.1515\/pp-2017-0006\n                    \n                  .","journal-title":"Pleura and Peritoneum"},{"key":"5658_CR17","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Sola\u00df","year":"2012","unstructured":"Sola\u00df W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849\u201355. \n                    https:\/\/doi.org\/10.1007\/s00464-012-2148-0\n                    \n                  .","journal-title":"Surg Endosc"},{"key":"5658_CR18","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ejso.2017.09.010","volume":"43","author":"M Alyami","year":"2017","unstructured":"Alyami M, Gagniere J, Sgarbura O, Cabelguenne D, Villeneuve L, Pezet D, Quenet F, Glehen O, Bakrin N, Passot G. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis. EJSO. 2017;43:2178\u201383. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2017.09.010\n                    \n                  .","journal-title":"EJSO"},{"key":"5658_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","volume":"44","author":"M Nowacki","year":"2018","unstructured":"Nowacki M, Alyami M, Villeneuve L, Mercier F, Hubner M, Willaert W, Ceelen W, Reymond M, Pezet D, Arvieux C, Khomyakov V, Lay L, Gianni S, Zegarski W, Bakrin N, Glehen O. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study. EJSO. 2018;44:991\u20136. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2018.02.014\n                    \n                  .","journal-title":"EJSO"},{"key":"5658_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.dib.2015.12.037","volume":"6","author":"E De Vlieghere","year":"2016","unstructured":"De Vlieghere E, Carlier C, Ceelen W, Bracke M, De Wever O. Data on in vivo selection of SK-OV-3 Luc ovarian cancer cells and intraperitoneal tumor formation with low inoculation numbers. Data Brief. 2016;6:542\u20139. \n                    https:\/\/doi.org\/10.1016\/j.dib.2015.12.037\n                    \n                  .","journal-title":"Data Brief"},{"key":"5658_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, M\u00fcrdter T, Giger-Pabst U, Strumberg D, Tempfer C, Zieren J, Schwab M, Reymond MA. Intraperitoneal chemotherapy of peritoneal Carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21:553\u20139. \n                    https:\/\/doi.org\/10.1245\/s10434-013-3213-1\n                    \n                  .","journal-title":"Ann Surg Oncol"},{"key":"5658_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","volume":"89","author":"RL Dedrick","year":"1997","unstructured":"Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997;89:480\u20137. \n                    https:\/\/doi.org\/10.1093\/jnci\/89.7.480\n                    \n                  .","journal-title":"J Natl Cancer Inst"},{"key":"5658_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.ejso.2018.04.020","volume":"44","author":"CB Tempfer","year":"2018","unstructured":"Tempfer CB, Hilal Z, Dogan A, Petersen M, Rezniczek GA. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis. Eur J Surg Oncol. 2018;44:1112\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2018.04.020\n                    \n                  .","journal-title":"Eur J Surg Oncol"},{"key":"5658_CR24","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00432-016-2234-0","volume":"142","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Kern AJP, Osma A, Kabakci B, Diaz-Carballo D, F\u00f6rster E, Zieren J, Fakhrian K. Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model. J Cancer Res Clin Oncol. 2016;142:2275\u201380. \n                    https:\/\/doi.org\/10.1007\/s00432-016-2234-0\n                    \n                  .","journal-title":"J Cancer Res Clin Oncol"},{"key":"5658_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00404-018-4784-7","volume":"298","author":"C Tempfer","year":"2018","unstructured":"Tempfer C, Giger-Pabst U, Hilal Z, Dogan A, Rezniczek GA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer. Arch Gynecol Obstet. 2018;298:234\u201357. \n                    https:\/\/doi.org\/10.1007\/s00404-018-4784-7\n                    \n                  .","journal-title":"Arch Gynecol Obstet"},{"key":"5658_CR26","doi-asserted-by":"crossref","unstructured":"Reymond MA, Solass W. PIPAC: pressurized IntraPeritoneal aerosol chemotherapy \u2013 Cancer under pressure. Berlin: Walter de Gruyter GmbH & Co KG; 2014.","DOI":"10.1515\/9783110366617"},{"issue":"4","key":"5658_CR27","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"Daniel G\u00f6hler","year":"2016","unstructured":"G\u00f6hler D, Khosrawipour V, Khosrawipour T, Diaz-Carballo D, Falkenstein TA, Zieren J, Stintz M, Giger-Pabst U. Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc. 2016:1\u20137. \n                    https:\/\/doi.org\/10.1007\/s00464-016-5174-5\n                    \n                  .","journal-title":"Surgical Endoscopy"},{"key":"5658_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejpb.2016.01.002","volume":"100","author":"C Try","year":"2016","unstructured":"Try C, Moulari B, B\u00e9duneau A, Fantini O, Pin D, Pellequer Y, Lamprecht A. Size dependent skin penetration of nanoparticles in murine and porcine dermatitis models. Eur J Pharm Biopharm. 2016;100:101\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2016.01.002\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"},{"key":"5658_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/MDER.S7409","volume":"4","author":"RN Dalby","year":"2011","unstructured":"Dalby RN, Eicher J, Zierenberg B. Development of Respimat\u00ae soft mist\u2122 inhaler and its clinical utility in respiratory disorders. Med Devices (Auckl). 2011;4:145\u201355. \n                    https:\/\/doi.org\/10.2147\/MDER.S7409\n                    \n                  .","journal-title":"Med Devices (Auckl)"},{"key":"5658_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","volume":"56","author":"NR Labiris","year":"2003","unstructured":"Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:588\u201399. \n                    https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01892.x\n                    \n                  .","journal-title":"Br J Clin Pharmacol"},{"key":"5658_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.12.040","volume":"406","author":"TC Carvalho","year":"2011","unstructured":"Carvalho TC, Peters JI, Williams RO. Influence of particle size on regional lung deposition \u2013 what evidence is there? Int J Pharm. 2011;406:1\u201310. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2010.12.040\n                    \n                  .","journal-title":"Int J Pharm"},{"key":"5658_CR32","doi-asserted-by":"publisher","unstructured":"Chaker MA. Key Parameters for the Performance of Impaction-Pin Nozzles Used in Inlet Fogging of Gas Turbine Engines 2005;4:91\u201397. doi:\n                    https:\/\/doi.org\/10.1115\/GT2005-68346\n                    \n                  .","DOI":"10.1115\/GT2005-68346"},{"key":"5658_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006563","volume":"96","author":"X Niu","year":"2017","unstructured":"Niu X, Song X, Su A, Zhao S, Li Q. Low-pressure capnoperitoneum reduces stress responses during pediatric laparoscopic high ligation of indirect inguinal hernia sac. Medicine (Baltimore). 2017;96:e6563. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000006563\n                    \n                  .","journal-title":"Medicine (Baltimore)"},{"key":"5658_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s004640000331","volume":"15","author":"TC Schmandra","year":"2001","unstructured":"Schmandra TC, Kim ZG, Gutt CN. Effect of insufflation gas and intraabdominal pressure on portal venous flow during pneumoperitoneum in the rat. Surg Endosc. 2001;15:405\u20138. \n                    https:\/\/doi.org\/10.1007\/s004640000331\n                    \n                  .","journal-title":"Surg Endosc"},{"key":"5658_CR35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.celrep.2012.08.009","volume":"2","author":"T Mashimo","year":"2012","unstructured":"Mashimo T, Takizawa A, Kobayashi J, Kunihiro Y, Yoshimi K, Ishida S, Tanabe K, Yanagi A, Tachibana A, Hirose J, Yomoda J, Morimoto S, Kuramoto T, Voigt B, Watanabe T, Hiai H, Tateno C, Komatsu K, Serikawa T. Generation and characterization of severe combined immunodeficiency rats. Cell Rep. 2012;2:685\u201394. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2012.08.009\n                    \n                  .","journal-title":"Cell Rep"},{"key":"5658_CR36","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/IGC.0000000000000497","volume":"25","author":"H Aza\u00efs","year":"2015","unstructured":"Aza\u00efs H, Queniat G, Bonner C, Kerdraon O, Tardivel M, Jetpisbayeva G, Frochot C, Betrouni N, Collinet P, Mordon S. Fischer 344 Rat: a preclinical model for epithelial ovarian Cancer folate-targeted therapy. Int J Gynecol Cancer. 2015;25:1194\u2013200. \n                    https:\/\/doi.org\/10.1097\/IGC.0000000000000497\n                    \n                  .","journal-title":"Int J Gynecol Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5658-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:11:58Z","timestamp":1588720318000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5658-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5658"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5658-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"5 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Animal Ethical Committee of the Faculty of Medicine, Ghent University, Belgium (ECD 17\u201350 and ECD 18\u201330). The human cell lines did not require ethics approval from our institution as they were purchased from legal commercial product.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"424"}}